Biopharma News

Apr 20, 2018
By BioPharm International Editors
LNC Therapeutics has appointed a new CEO and is strengthening its R&D for gut microbiome-based drugs.
Apr 19, 2018
By BioPharm International Editors
Johnson & Johnson’s Janssen partners with Bristol-Myers Squibb to advance next-generation therapies for cardiovascular diseases.
Apr 19, 2018
By BioPharm International Editors
The agency has granted breakthrough therapy designation to Roche’s hemophilia therapy for treating hemophilia A in patients without factor VIII inhibitors.
Apr 19, 2018
By BioPharm International Editors
The transaction is part of Merck KGaA’s strategy to actively shape its product portfolio and focus on innovation-driven business.
Apr 19, 2018
By BioPharm International Editors
Global investment firm Advent to acquire and invest in Sanofi’s European generics business, Zentiva, to boost its position in European market.
Apr 17, 2018
By BioPharm International Editors
According to Alexion, the acquisition will help rebuild its clinical pipeline.
Apr 12, 2018
By BioPharm International Editors
The new facility, to be built in Toronto, Canada, will significantly increase capacity for pediatric and booster vaccines.
Apr 11, 2018
By BioPharm International Editors
The biopharmaceutical firm has chosen Rhode Island as the site of its next-generation biomanufacturing plant, which will offer flexibility, speed, and efficiency.
Apr 09, 2018
By BioPharm International Editors
Celltrion received complete response letters from FDA for its rituximab and trastuzumab biosimilars.
Apr 09, 2018
By BioPharm International Editors
Under this global collaboration, the companies will develop encapsulated cell therapies for treating Type 1 diabetes.
native1_300x100
lorem ipsum